Christopher Parrish
Impact in
- Hematology top 5%
- Multiple Myeloma Research and Treatments
- Oncology top 10%
- CAR-T cell therapy research
- Peptidase Inhibition and Analysis
- Cancer Treatment and Pharmacology
Papers in
- Hematology 25
- Multiple Myeloma Research and Treatments 24
- Oncology 19
- Cancer Treatment and Pharmacology 8
- CAR-T cell therapy research 5
- Peptidase Inhibition and Analysis 4
- Co-authors
- Gordon Cook (26 shared papers)Alan Melcher (10 shared papers)Gina B. Scott (9 shared papers)Matt Coffey (7 shared papers)Elizabeth J. Ilett (6 shared papers)Kevin J. Harrington (5 shared papers)Richard G. Vile (5 shared papers)Hardev Pandha (5 shared papers)
- Journals
- Blood (11 papers)Molecular Therapy (4 papers)British Journal of Haematology (2 papers)Leukemia (2 papers)Biology of Blood and Marrow Transplantation (2 papers)
- Partner nations
- United KingdomUnited StatesCanada
In The Last Decade
Christopher Parrish
38 papers receiving 686 citations
Peers
Comparison fields: 5 of 75
- Hematology 319
- Oncology 364
- Immunology 187
- Genetics 199
- Biotechnology 46
Countries citing papers authored by Christopher Parrish
This map shows the geographic impact of Christopher Parrish's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher Parrish with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher Parrish more than expected).
Fields of papers citing papers by Christopher Parrish
This network shows the impact of papers produced by Christopher Parrish. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher Parrish. The network helps show where Christopher Parrish may publish in the future.
Co-authors
The 25 scholars most cited alongside Christopher Parrish, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 42 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 154 | |
| 2 | 2016 | 96 | |
| 3 | 2014 | 95 | |
| 4 | 2012 | 63 | |
| 5 | 2015 | 32 | |
| 6 | 2003 | 26 | |
| 7 | 2009 | 26 | |
| 8 | 2012 | 22 | |
| 9 | 2015 | 22 | |
| 10 | 2003 | 21 | |
| 11 | 2021 | 14 | |
| 12 | 2021 | 12 | |
| 13 | 2014 | 11 | |
| 14 | 2022 | 10 | |
| 15 | The effects of cytokine gene transfer into tumors on host cell infiltration and regression. | 1996 | 10 |
| 16 | 2023 | 8 | |
| 17 | 2019 | 7 | |
| 18 | 2014 | 7 | |
| 19 | 2015 | 7 | |
| 20 | 2015 | 6 |
About Christopher Parrish
Christopher Parrish is a scholar working on Hematology, Oncology, Molecular Biology, Immunology and Genetics, having authored 42 papers that have together received 698 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (24 papers), Immunotherapy and Immune Responses (10 papers), Protein Degradation and Inhibitors (9 papers), Virus-based gene therapy research (9 papers), Cancer Treatment and Pharmacology (8 papers), Cancer Research and Treatments (6 papers), CAR-T cell therapy research (5 papers) and Peptidase Inhibition and Analysis (4 papers). The work is most often cited by research in Hematology (319 citations), Oncology (364 citations), Immunology (187 citations), Genetics (199 citations) and Biotechnology (46 citations). Christopher Parrish has collaborated with scholars based in United Kingdom, United States and Canada. Frequent co-authors include Gordon Cook, Alan Melcher, Gina B. Scott, Matt Coffey, Elizabeth J. Ilett, Kevin J. Harrington, Richard G. Vile, Hardev Pandha, Karishma Rajani and Shane Zaidi. Their work appears in journals such as Blood, Molecular Therapy, British Journal of Haematology, Leukemia and Biology of Blood and Marrow Transplantation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.